&nbsp;

Thymic-Diagnosis-Pathway.pdf

New

May 2025

Document

Thymic-Follow-Up-Pathway.pdf

New

May 2025

Document

Thymic-Treatment-Pathway.pdf

New

May 2025

Guidelines and Advice

The Use of Indoor Tanning Devices and the Risk of Developing Cutaneous Malignant Melanoma: A Systematic Review and Clinical Practice Guideline

Status: In-Review
ID: 8-8

Aug 2014

Non-Hodgkin Lymphoma

Regimen

TRBC(MNT)

Cancer Type:

Sarcoma,

Soft Tissue

Intent: Palliative

Drugs Used:

trabectedin (Unfunded)

Quick Link(s):

Regimen Monograph

May 2025

Regimen

NIVL(MNT)

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - Advanced Melanoma (Unresectable or Metastatic Melanoma)

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

May 2025

Regimen

NIVL+IPIL

Cancer Type:

Skin,

Melanoma

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

Drugs Used:

nivolumab,

ipilimumab

Quick Link(s):

Regimen Monograph

May 2025

Regimen

NIVL

Cancer Type:

Skin,

Melanoma

Intent: Adjuvant

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

May 2025

Document

Taking-Care-of-Someone-Who-is-ill.pdf

New

Jun 2025

Drug

nivolumab

Other Name(s): Opdivo®

Quick Link(s): Drug Monograph, Patient Info Sheet

Oct 2024

Document